🔥🐔 BizChicken 🐔🔥
Companies Similar to Dermata Therapeutics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Arcutis Biotherapeutics, Inc.
ARQ-151
Arcutis Biotherapeutics, Inc. is a biopharmaceutical company developing and commercializing treatments for dermatological diseases, including plaque psoriasis, atopic dermatitis, seborrheic dermatitis, scalp psoriasis, hand eczema, vitiligo, and alopecia areata.
About | ESG | About | About | About | Contact | Careers | About | Jobs | Jobs | About | About | About | About
Symbol: ARQT
Recent Price: $14.20
Industry: Biotechnology
CEO: Mr. Todd Franklin Watanabe M.A.
Sector: Healthcare
Employees: 296
Address: 3027 Townsgate Road, Westlake Village, CA 91361
Phone: 805 418 5006
Last updated: 2024-12-31
Dianthus Therapeutics, Inc.
DNTH103
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company focused on designing, developing, and delivering novel monoclonal antibodies for severe autoimmune and inflammatory diseases. Their lead product, DNTH103, is in phase 1 clinical trials.
Careers | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | About | About
Symbol: DNTH
Recent Price: $21.50
Industry: Biotechnology
CEO: Mr. Marino Garcia M.B.A.
Sector: Healthcare
Employees: 53
Address: 7 Times Square, New York, NY 10036
Phone: 929-999-4055
Last updated: 2024-12-31
Oncternal Therapeutics, Inc.
zilovertamab, ONCT-216, ONCT-808, ONCT-534
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.
Symbol: ONCT
Recent Price: $0.53
Industry: Biotechnology
CEO: Dr. James B. Breitmeyer M.D., Ph.D.
Sector: Healthcare
Employees: 27
Address: 12230 El Camino Real, San Diego, CA 92130
Phone: 858 434 1113
Last updated: 2024-12-31
Travere Therapeutics, Inc.
Chenodal, Cholbam, Thiola, Sparsentan, TVT-058
Travere Therapeutics, Inc. is a biopharmaceutical company that focuses on identifying, developing, commercializing, and delivering therapies for the treatment of rare diseases. Its products include Chenodal, Cholbam, Thiola, and candidates like Sparsentan and TVT-058.
About | Leadership | About | About | About | Contact | Contact | Careers | Careers | About | News | About | About | About | About | About | About | News | Events | About | About | ESG | About | Jobs | Jobs | Careers | About | About | About | About
Symbol: TVTX
Recent Price: $17.32
Industry: Biotechnology
CEO: Dr. Eric M. Dube Ph.D.
Sector: Healthcare
Employees: 380
Address: 3611 Valley Centre Drive, San Diego, CA 92130
Phone: 888 969 7879
Leadership
- Eric Dube, Ph.D., President & Chief Executive Officer
- Chris Cline, CFA, Chief Financial Officer
- Angela Giannantonio, Senior Vice President, Human Resources
- Peter Heerma, Chief Commercial Officer
- Jula Inrig, M.D., Chief Medical Officer
- Casey Logan, Chief Business Officer
- Elizabeth Reed, J.D., Senior Vice President, General Counsel, Corporate Secretary
- William Rote, Ph.D., Senior Vice President, Research & Development
- Charlotte Smith, Senior Vice President, Public Affairs
- Gary A. Lyons, Chairman
- Roy D. Baynes, M.D., Ph.D.,
- Suzanne L. Bruhn, Ph.D.,
- Tim Coughlin, CPA,
- Jeffrey A. Meckler,
- John A. Orwin,
- Sandra E. Poole,
- Ron Squarer,
- Ruth Williams-Brinkley, FACHE,
Last updated: 2024-12-31
Aclaris Therapeutics, Inc.
Zunsemetinib
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immune-inflammatory diseases. It operates through Therapeutics and Contract Research segments, addressing unmet needs with innovative therapies, including treatments for rheumatoid and psoriatic arthritis, atopic dermatitis, autoimmune diseases, inflammatory bowel disease, and certain cancers.
Contact | Careers | About | About | Directors | Leadership | About | Careers | About | About | Jobs
Symbol: ACRS
Recent Price: $2.48
Industry: Medical - Diagnostics & Research
CEO: Dr. Neal S. Walker D.O., M.D.
Sector: Healthcare
Employees: 86
Address: 640 Lee Road, Wayne, PA 19087
Phone: 484 324 7933
Last updated: 2024-12-31
Black Diamond Therapeutics, Inc.
BDTX-189, BDTX-1535, BDTX-4933
Black Diamond Therapeutics, Inc. is a biotechnology company that discovers, develops, and commercializes medicines for patients with genetically defined tumors. The company focuses on creating irreversible small molecule inhibitors to target specific oncogenic proteins.
Symbol: BDTX
Recent Price: $2.15
Industry: Biotechnology
CEO: Dr. Mark A. Velleca M.D., Ph.D.
Sector: Healthcare
Employees: 54
Address: One Main Street, Cambridge, MA 02142
Phone: 617 252 0848
Leadership
- Ali Behbahani, M.D., Co-Head of Healthcare, NEA
- Shannon Campbell, Executive Vice President and Chief Commercial Officer, Merus
- Kapil Dhingra, M.D., Former Head, Roche Oncology Development
- Samarth (Sam) Kulkarni, Ph.D., CEO, CRISPR Therapeutics AG
- Garry E. Menzel, Ph.D., Operating Partner, GHO Capital Partners LLP
- Prakash Raman, Ph.D., CEO of InduPro, Inc.
- Mark A. Velleca, M.D., Ph.D., CEO and Board Chair
Last updated: 2024-12-31
Biomerica, Inc.
diagnostic and therapeutic products
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.
About | About | Contact | Contact | About | News | News | About | About | About | About | About
Symbol: BMRA
Recent Price: $0.31
Industry: Medical - Devices
CEO: Mr. Zackary S. Irani
Sector: Healthcare
Employees: 64
Address: 17571 Von Karman Avenue, Irvine, CA 92614
Phone: 949 645 2111
Last updated: 2024-12-31
Journey Medical Corporation
Qbrexza, Accutane, Targadox, Ximino, Exelderm
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for treating dermatological conditions in the United States. It offers various products for hyperhidrosis and acne treatment and more.
Symbol: DERM
Recent Price: $3.97
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Claude Maraoui
Sector: Healthcare
Employees: 41
Address: 9237 East Via de Ventura Boulevard, Scottsdale, AZ 85258
Phone: 480 434 6670
Last updated: 2024-12-31
DarioHealth Corp.
Dario's metabolic solutions
Dario Health Corp. is a digital therapeutics company offering solutions for metabolic health, MSK conditions, behavioral health, and chronic condition management.
Symbol: DRIO
Recent Price: $0.79
Industry: Medical - Diagnostics & Research
CEO: Mr. Erez Raphael
Sector: Healthcare
Employees: 223
Address: 18 West 18th Street, New York, NY 10011
Phone: 833 914 3796
Last updated: 2024-12-31
Dermata Therapeutics, Inc.
DMT310
Dermata Therapeutics, Inc. is a clinical-stage biotechnology company specializing in the development and commercialization of pharmaceutical candidates for treating medical and aesthetic skin conditions. The company focuses on products such as DMT310 for acne, rosacea, and psoriasis, and DMT410 for hyperhidrosis and aesthetic conditions.
Symbol: DRMA
Recent Price: $1.34
Industry: Biotechnology
CEO: Mr. Gerald T. Proehl
Sector: Healthcare
Employees: 8
Address: 3525 Del Mar Heights Road, San Diego, CA 92130
Phone: 858 800 2543
Last updated: 2024-12-31
4D Molecular Therapeutics, Inc.
4D-125, 4D-110, 4D-310, 4D-150, 4D-710
4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company developing product candidates using adeno-associated virus vectors, focusing on ophthalmology, cardiology, and pulmonology.
About | About | Contact | News | News | News | Careers | Careers | About | DEI | Careers | Leadership | Careers | Careers
Symbol: FDMT
Recent Price: $5.30
Industry: Biotechnology
CEO: Dr. David H. Kirn M.D.
Sector: Healthcare
Employees: 201
Address: 5858 Horton Street, EmeryVille, CA 94608
Phone: 510 505 2680
Last updated: 2024-12-31
Fractyl Health, Inc. Common Stock
Revita DMR System
Fractyl Health, Inc. develops therapies for type 2 diabetes and obesity, including the Revita DMR System and Rejuva gene therapy platform.
Symbol: GUTS
Recent Price: $2.03
Industry: Biotechnology
CEO: Dr. Harith Rajagopalan M.D., Ph.D.
Sector: Healthcare
Employees: 112
Address: 17 Hartwell Avenue, Lexington, null 02421
Phone: 781-902-8800
Last updated: 2024-12-31
Kiora Pharmaceuticals, Inc.
KIO-301
Kiora Pharmaceuticals, Inc. develops therapies for ophthalmic diseases, with lead product KIO-301 in Phase 1 trial for vision restoration in degenerative retinal diseases and other products in trials for conditions like rheumatoid arthritis-related ocular issues and corneal wound repair.
Symbol: KPRX
Recent Price: $3.30
Industry: Biotechnology
CEO: Dr. Brian M. Strem Ph.D.
Sector: Healthcare
Employees: 12
Address: 1371 East 2100 South, Salt Lake City, UT 84105
Phone: 781 788 8869
Last updated: 2024-12-31
PDS Biotechnology Corporation
PDS0101
PDS Biotechnology Corporation is a clinical-stage biopharmaceutical company focused on developing multifunctional cancer immunotherapies. Its lead product candidate, PDS0101, is in Phase II clinical trial for treating various human papillomavirus-associated malignancies.
Symbol: PDSB
Recent Price: $1.69
Industry: Biotechnology
CEO: Dr. Frank K. Bedu-Addo Ph.D.
Sector: Healthcare
Employees: 25
Address: 25B Vreeland Road, Florham Park, NJ 07932
Phone: 800 208 3343
Leadership
- Frank Bedu-Addo, Ph.D., Chief Executive Officer, Director
- Stephan Toutain, Chief Operating Officer
- Lars Boesgaard, Chief Financial Officer
- Gregory Conn, Ph.D., Chief Scientific Officer
- Kirk Shepard, M.D., Chief Medical Officer
- Spencer Brown, Senior Vice-President, General Counsel, Corporate Secretary and Compliance Officer
- Rory Cullinane, Vice President of Quality
- Joe Dervan, Ph.D., Vice President of Research and Development
- David Schaaf, M.D., Vice President of Medical Affairs
- Sir Richard Sykes, Director
- Ilian Iliev, Ph.D., Director
- Gregory Freitag, J.D., CPA, Director
- Otis W. Brawley, M.D., Director
- Kamil Ali-Jackson, J.D., Director
- Stephen Glover, Chairman
Last updated: 2024-12-31
Revance Therapeutics, Inc.
Daxibotulinumtoxin A
Revance Therapeutics, Inc. is a biotechnology company focused on developing, manufacturing, and commercializing neuromodulators for various aesthetic and therapeutic indications.
Leadership | About | About | Contact | Contact | About | About | About | Careers | Culture | Benefits | Directors | About | Sustainability | About | News | Events | About | About | About | About
Symbol: RVNC
Recent Price: $3.06
Industry: Biotechnology
CEO: Mr. Mark J. Foley
Sector: Healthcare
Employees: 597
Address: 1222 Demonbreun Street, Nashville, TN 37203
Phone: 615 724 7755
Leadership
- Mark J. Foley, Chief Executive Officer
- Tobin Schilke, Chief Financial Officer
- Erica Jordan, Chief Commercial Officer
- Dwight O. Moxie, Chief Legal Officer and General Counsel
- Amie Krause, Chief People Officer
- David A. Hollander, Chief Medical Officer, Global Therapeutics Franchise Lead
- Angus C. Russell, CHAIRMAN OF THE BOARD, CHAIR, NOMINATING AND GOVERNANCE COMMITTEE
- Chris Nolet, Chair, Audit Committee
- Jill Beraud, CHAIR, BRAND COMMITTEE, COMPENSATION COMMITTEE
- Vlad Coric,
- Julian S. Gangolli,
- Carey O’Connor Kolaja,
- Olivia C. Ware,
Last updated: 2024-12-31
STRATA Skin Sciences, Inc.
XTRAC, Pharos, VTRAC, Thera Clear
STRATA Skin Sciences, Inc. is a medical technology company specializing in the development, commercialization, and marketing of products for treating various dermatologic conditions. The company serves markets across the globe with products like excimer lasers and lamp systems.
Symbol: SSKN
Recent Price: $2.95
Industry: Medical - Devices
CEO: Dr. Dolev Rafaeli Ph.D.
Sector: Healthcare
Employees: 99
Address: 5 Walnut Grove Drive, Horsham, PA 19044
Phone: 215 619 3200
Last updated: 2024-12-31
Verrica Pharmaceuticals Inc.
VP-102, VP-103
Verrica Pharmaceuticals Inc. develops and commercializes treatments for skin diseases in the United States, including products for molluscum contagiosum and warts. The company collaborates with Torii Pharmaceutical Co., Ltd., and Lytix Biopharma AS for further development and commercialization efforts.
Symbol: VRCA
Recent Price: $0.70
Industry: Biotechnology
CEO: Mr. Ted White
Sector: Healthcare
Employees: 100
Address: 44 West Gay Street, West Chester, PA 19380
Phone: 484 453 3300
Last updated: 2024-12-31
DiaMedica Therapeutics Inc.
DM199
Dia Medica Therapeutics Inc. is a clinical stage biopharmaceutical company developing treatments for neurological and kidney diseases, including their lead drug candidate DM199 for chronic kidney disease and acute ischemic stroke.
Symbol: DMAC
Recent Price: $5.34
Industry: Biotechnology
CEO: Mr. Dietrich John Pauls MBA
Sector: Healthcare
Employees: 18
Address: Two Carlson Parkway, Minneapolis, MN 55447
Phone: 763 612 6755
Leadership
- Rick Pauls, President & CEO
- Lorianne Masuoka, Chief Medical Officer
- Scott Kellen, Chief Financial Officer
- Ambarish Shah, Ph.D., Chief Technology Officer
- Dominic Cundari, Chief Commercial Officer
- David Wambeke, Chief Business Officer
- Rebekah de Vitry Fries, Vice President of Clinical Operations
- Dr. Paolo Madeddu, MD, Senior Scientific Advisor and KLK1 Expert
Last updated: 2024-12-31
Relmada Therapeutics, Inc.
Esmethadone (d-methadone, dextromethadone, REL-1017)
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company specializing in developing products for central nervous system (CNS) diseases. Their lead product, Esmethadone, is in Phase 3 clinical trials for treating major depressive disorder.
Symbol: RLMD
Recent Price: $0.46
Industry: Biotechnology
CEO: Dr. Sergio Traversa M.B.A., Pharm.D.
Sector: Healthcare
Employees: 20
Address: 2222 Ponce de Leon Boulevard, Coral Gables, FL 33134
Phone: 786 629 1376
Last updated: 2024-12-31
Seelos Therapeutics, Inc.
SLS-002, SLS-005, SLS-006, SLS-007, SLS-008, SLS-004, SLS-010
Seelos Therapeutics, Inc. is focused on developing and commercializing therapeutics for central nervous system, respiratory, and other disorders, with lead programs targeting major depressive disorders, amyotrophic lateral sclerosis, Sanfilippo syndrome, and Parkinson's disease.
Symbol: SEEL
Recent Price: $0.37
Industry: Biotechnology
CEO: Dr. Raj Mehra J.D., Ph.D.
Sector: Healthcare
Employees: 8
Address: 300 Park Avenue, New York, NY 10022
Phone: 646 293 2100
Last updated: 2024-12-31